Printer Friendly

DIAGNON ACQUIRES ASSETS, RIGHTS TO TSI DIVISION CONTRACTS

 ROCKVILLE, Md., June 28 /PRNewswire/ -- Diagnon Corporation (OTC Bulletin Board: 3DIGN) has acquired the assets and the rights to certain contracts of TSI Corporation (NASDAQ-NMS: TSIN), L.A.S. Division. This division has provided comprehensive laboratory animal services for the past 15 years to government and commercial clients. The extensive experience in the maintenance and breeding of research animals, including non-human primates, rabbits, mice, rats and guinea pigs complements and expands the research efforts now being performed by Diagnon's subsidiary, BIOQUAL. The TSI division generated in excess of $700,000 in sales this past year. The programs and personnel will be absorbed into BIOQUAL's present facilities, allowing for improved efficiency and competitiveness.
 BIOQUAL holds several contracts for the National Institutes of Health and also provides custom services in the areas of rodent models for cancer, immunology, contraceptive development and evaluation, transgenic manipulation and breeding; and non-human primate models for contraceptive development and evaluation, cancer, AIDS, SIV, cystic fibrosis, influenza and hepatitis. Diagnon also provides consulting services with regard to meeting environmental enrichment requirements for non-human primates as prescribed by the USDA.
 Diagnon's common stock is carried on the OTC Bulletin Board under the symbol 3DIGN.
 -0- 6/28/93
 /CONTACT: John C. Landon, chief executive officer, Diagnon Corporation, 301-251-2801/
 (3DIGN TSIN)


CO: Diagnon Corporation; TSI Corporation, L.A.S. Division ST: Maryland IN: MTC SU: CON

TW-IH -- DC026 -- 6337 06/28/93 14:44 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 28, 1993
Words:235
Previous Article:LTV PENSION FUNDING SUBSTANTIALLY IMPROVED
Next Article:PORTABILITY FIGURES SHOW SPRINT WINNING BATTLE FOR 800 NUMBER CUSTOMERS
Topics:


Related Articles
DIAGNON CORPORATION ISSUES REPORT FOR FISCAL YEAR ENDED MAY 31, 1992
DIAGNON CORPORATION REPORTS RESULTS FOR ITS FIRST QUARTER
LETTER OF INTENT SIGNED FOR DIAGNON TO ACQUIRE 20 PERCENT OF ZOOQUEST STOCK
DIAGNON REPORTS SECOND QUARTER RESULTS
DIAGNON CORPORATION REPORTS THIRD QUARTER RESULTS
DIAGNON CORPORATION REPORTS RESULTS FOR ITS FISCAL YEAR
DIAGNON CORPORATION ENTERS INTO PRELIMINARY AGREEMENT
DIAGNON AND JOHNS HOPKINS UNIVERSITY AGREE ON CANCER RESEARCH PROJECT
Diagnon Corporation Reports Internal Reorganization and Personnel Promotions
BIOQUAL Division of Reproductive Endocrinology and Toxicology Presents Data On the Mechanism of a Male Antifertility Drug

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters